220
Participants
Start Date
October 10, 2021
Primary Completion Date
March 1, 2022
Study Completion Date
March 1, 2022
Degludec
Treatment with insulin degludec when compared to insulin glargine U-300 will result in similar blood glucose control in hospitalized patients with type 2 diabetes.
Glargine U300
Treatment with insulin glargine U300 when compared to insulin degludec will result in similar blood glucose control in hospitalized patients with type 2 diabetes.
Division Of Endocrinology and Diabetes , Medanta The Medicity Hospital, Gurgaon
Medanta, The Medicity, India
OTHER